DJO announced the acquisition of foot and ankle player Trilliant Surgical. The move comes on the heels of DJO’s November 2020 purchase of Stryker’s STAR Total Ankle system. DJO owner Colfax values the foot and ankle reconstruction market at over $1 billion with a high growth rate.
Colfax CEO Matt Trerotola said, “When we were doing the planning for the acquisition of DJO, we looked at whether there were attractive adjacencies. Foot and ankle was one that had attractive growth, good structure and good possibilities. In addition, the fragmentation of the foot and ankle space presents multiple paths for acquisition-based expansion.”
With the addition of Trilliant’s portfolio of reconstruction and fixation products, DJO gains a dedicated foot and ankle business line. The company cited a rapidly aging population, sports-related injuries and increased prevalence of diabetes as key drivers of the foot and ankle market.
Brady Shirley, CEO of DJO, said, “Trilliant’s market-leading portfolio of foot and ankle solutions complements our acquisition of the STAR™ system and creates a dedicated foot and ankle business. We are committed to building our Reconstructive segment and believe that the foot and ankle space is a great fit for our focused innovation and solutions approach that has allowed DJO to be a growth leader in the upper extremity market for many years.”
DJO announced the acquisition of foot and ankle player Trilliant Surgical. The move comes on the heels of DJO’s November 2020 purchase of Stryker’s STAR Total Ankle system. DJO owner Colfax values the foot and ankle reconstruction market at over $1 billion with a high growth rate.
Colfax CEO Matt Trerotola said, “When we were doing the...
DJO announced the acquisition of foot and ankle player Trilliant Surgical. The move comes on the heels of DJO’s November 2020 purchase of Stryker’s STAR Total Ankle system. DJO owner Colfax values the foot and ankle reconstruction market at over $1 billion with a high growth rate.
Colfax CEO Matt Trerotola said, “When we were doing the planning for the acquisition of DJO, we looked at whether there were attractive adjacencies. Foot and ankle was one that had attractive growth, good structure and good possibilities. In addition, the fragmentation of the foot and ankle space presents multiple paths for acquisition-based expansion.”
With the addition of Trilliant’s portfolio of reconstruction and fixation products, DJO gains a dedicated foot and ankle business line. The company cited a rapidly aging population, sports-related injuries and increased prevalence of diabetes as key drivers of the foot and ankle market.
Brady Shirley, CEO of DJO, said, “Trilliant’s market-leading portfolio of foot and ankle solutions complements our acquisition of the STAR™ system and creates a dedicated foot and ankle business. We are committed to building our Reconstructive segment and believe that the foot and ankle space is a great fit for our focused innovation and solutions approach that has allowed DJO to be a growth leader in the upper extremity market for many years.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.
Copy to clipboard 
